Feb 26 2024University of Bristol
Using primary care records from the UK GP database Clinical Practice Research Datalink , which contains data from a network of over 2,000 GPs from more than 670 practices across the UK, the researchers examined if this theory could be supported. The researchers found long-term glitazone drug use by diabetic patients was associated with reduced primary and secondary brain tumor risk compared with diabetic patients on other medications. No association was found between fibrate use for hyperlipidaemic patients and any type of brain tumor.
This is the largest study in diabetic patients showing a link between long-term glitazone use and decreased primary brain tumor and brain metastasis.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: